CLINICAL_TRIALS
trial_result
· 2011-08-25
Clinical Trial Update: Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus. [Phase 3]
Summary
Phase 3 trial evaluating alogliptin in combination with a sulfonylurea for Type 2 diabetes mellitus has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2011-08-25